Claude C. Warzecha

发表

MADS+: discovery of differential splicing events from Affymetrix exon junction array data

Shihao Shen, Claude C. Warzecha, Russ P. Carstens, 2009, Bioinform..

The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events

Claude C. Warzecha, Y. Xing, R. Carstens, 2009, RNA biology.

THEMIS enhances TCR signaling and enables positive selection by selective inhibition of SHP-1

Claude C. Warzecha, L. Aravind, P. Love, 2017, Nature Immunology.

An ESRP‐regulated splicing programme is abrogated during the epithelial–mesenchymal transition

Yi Xing, Shihao Shen, Claude C. Warzecha, 2010, The EMBO journal.

Determination of a Comprehensive Alternative Splicing Regulatory Network and Combinatorial Regulation by Key Factors during the Epithelial-to-Mesenchymal Transition

Yi Xing, Yang Guo, Claude C. Warzecha, 2016, Molecular and Cellular Biology.

Prednisolone reduces the interferon response to AAV in cynomolgus macaques and may increase liver gene expression

Claude C. Warzecha, Lili Wang, M. Betts, 2022, Molecular therapy. Methods & clinical development.

Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver.

Claude C. Warzecha, Margaret M. Billingsley, Timothy J. Murdoch, 2021, Biomaterials science.

The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression.

Claude C. Warzecha, S. Berger, S. Sykes, 2008, Molecular cell.

Themis2 lowers the threshold for B cell activation during positive selection

Claude C. Warzecha, H. Ferry, M. Marcellin, 2016, Nature Immunology.

Long-term Stable Reduction of Low-density Lipoprotein in Nonhuman Primates Following In Vivo Genome Editing of PCSK9.

Claude C. Warzecha, Mingyao Li, Lili Wang, 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing.

Claude C. Warzecha, R. Carstens, J. Hogenesch, 2009, Molecular cell.

Ldb1 complexes: the new master regulators of erythroid gene transcription.

Claude C. Warzecha, P. Love, Liqi Li, 2014, Trends in genetics : TIG.

HIRA, a DiGeorge Syndrome Candidate Gene, Confers Proper Chromatin Accessibility on HSCs and Supports All Stages of Hematopoiesis.

Claude C. Warzecha, K. Ozato, P. Adams, 2020, Cell reports.

Ldb1 is required for Lmo2 oncogene-induced thymocyte self-renewal and T-cell Acute Lymphoblastic Leukemia.

Claude C. Warzecha, Bryan J. Venters, Kairong Cui, 2020, Blood.

Complex changes in alternative pre-mRNA splicing play a central role in the epithelial-to-mesenchymal transition (EMT).

Claude C. Warzecha, R. Carstens, 2012, Seminars in cancer biology.

The splicing regulators Esrp1 and Esrp2 direct an epithelial splicing program essential for mammalian development

Claude C. Warzecha, B. Cieply, T. Bebee, 2015, eLife.

Scalable mRNA and siRNA Lipid Nanoparticle Production Using a Parallelized Microfluidic Device.

Claude C. Warzecha, D. Weissman, Lili Wang, 2021, Nano letters.

Identification of RNA-binding proteins that regulate FGFR2 splicing through the use of sensitive and specific dual color fluorescence minigene assays.

Claude C. Warzecha, R. Carstens, R. Jones, 2006, RNA.

Characterization of sequences and mechanisms through which ISE/ISS-3 regulates FGFR2 splicing

Claude C. Warzecha, R. Carstens, R. Hovhannisyan, 2006, Nucleic acids research.

Dynamic fluorescent and luminescent reporters for cell-based splicing screens.

Claude C. Warzecha, R. Carstens, R. Hovhannisyan, 2012, Methods in molecular biology.

ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing.

Claude C. Warzecha, R. Carstens, J. Hogenesch, 2009, Molecular cell.